Resource Type

Journal Article 194

Conference Videos 6

Conference Information 1

Year

2024 7

2023 23

2022 18

2021 26

2020 5

2019 18

2018 13

2017 5

2016 13

2015 11

2014 8

2013 8

2012 13

2011 7

2010 7

2009 11

2008 1

2007 2

2000 2

open ︾

Keywords

cancer 28

lung cancer 16

Cancer 9

breast cancer 8

cervical cancer 8

cancer therapy 7

Colorectal cancer 5

targeted therapy 5

prostate cancer 4

Diagnosis 3

cancer immunotherapy 3

drug resistance 3

immunotherapy 3

Artificial intelligence 2

Breast cancer 2

COVID-19 2

DNA methylation 2

Exosomes 2

Glycosylation 2

open ︾

Search scope:

排序: Display mode:

Midline2 is overexpressed and a prognostic indicator in human breast cancer and promotes breast cancer

Frontiers of Medicine 2021, Volume 15, Issue 6,   Pages 942-942 doi: 10.1007/s11684-021-0876-z

Midline2 is overexpressed and a prognostic indicator in human breast cancer and promotes breast cancer

Lan Wang,Jueheng Wu,Jie Yuan,Xun Zhu,Hongmei Wu,Mengfeng Li

Frontiers of Medicine 2016, Volume 10, Issue 1,   Pages 41-51 doi: 10.1007/s11684-016-0429-z

Abstract: However, the role of MID2 in breast cancer remains unknown.This study investigated the expression, prognostic value, and role of MID2 in breast cancer.The expression of MID2 mRNA and protein was significantly upregulated in breast cancer tissue and establishedcancer tissue.This study indicated that MID2 may be a novel prognostic marker and interventional target in breast cancer

Keywords: breast cancer     MID2     proliferation     overall survival     xenograft    

Meta-analysis of the risk factors of breast cancer concerning reproductive factors and oral contraceptive

Qiong DAI MD, Bei LIU MD, Yukai DU MM,

Frontiers of Medicine 2009, Volume 3, Issue 4,   Pages 452-458 doi: 10.1007/s11684-009-0080-z

Abstract: studies that addressed whether reproductive factors and oral contraceptive use were associated with breastcancer by searching the MEDLINE, PubMed, Proquest, Embase, ScienceDirect, African Healthline, BMJ Healthcancer risk while the summary OR based on number of full-term pregnancies ≥1 (OR, 0.63*; 95% CIbreast cancer risk.cancer risk while breast-feeding and number of full-term pregnancies ≥1 are protective factors

Keywords: meta-analysis     breast cancer     risk factors     reproductive factors     oral contraceptive use    

Metabolism and immunity in breast cancer

Deyu Zhang, Xiaojie Xu, Qinong Ye

Frontiers of Medicine 2021, Volume 15, Issue 2,   Pages 178-207 doi: 10.1007/s11684-020-0793-6

Abstract: Breast cancer is one of the most common malignancies that seriously threaten women’s health.In the process of the malignant transformation of breast cancer, metabolic reprogramming and immune evasionBreast cancer cells generate energy through increased glucose metabolism.For tumor-associated immunity, poor immunogenicity and heightened immunosuppression cause breast cancercancer.

Keywords: breast cancer     metabolism     immunity     cancer stem cells    

A comprehensive information database (CID) of breast cancer patients in China

Shuai Li, Li Fu

Frontiers of Medicine 2012, Volume 6, Issue 2,   Pages 212-216 doi: 10.1007/s11684-012-0185-7

Production of pectic extracts from sugar beet pulp with antiproliferative activity on a breast cancer

Jacqueline CONCHA, Caroline WEINSTEIN, María Elvira Zú?IGA

Frontiers of Chemical Science and Engineering 2013, Volume 7, Issue 4,   Pages 482-489 doi: 10.1007/s11705-013-1342-5

Abstract: which depends on the extraction method, is decisive in their capacity to induce apoptosis on several cancercell lines like colon, prostate and breast.The pectic extract was examined for its antiproliferative activity on the MCF-7 breast cancer cell line

Keywords: pectic extracts     antiproliferative activity     breast cancer     enzymatic treatment    

Breast cancer-associated fibroblasts: their roles in tumor initiation, progression and clinical applications

Aixiu Qiao,Feng Gu,Xiaojing Guo,Xinmin Zhang,Li Fu

Frontiers of Medicine 2016, Volume 10, Issue 1,   Pages 33-40 doi: 10.1007/s11684-016-0431-5

Abstract:

Breast cancer is the most common malignant tumor in women, and the incidence of this disease has increasedPrevious studies focused on cancer cells, but an increasing number of recent studies have analyzed thecontribution of cancer microenvironment to the initiation and progression of breast cancer.also serve as biomarkers in the clinical diagnosis, therapy, and prognosis of breast cancer.In this article, we reviewed the literature and summarized the research findings on CAFs in breast cancer

Keywords: cancer-associated fibroblast     breast cancer     progression     prognosis    

Decitabine induces -mediated immune responses in p53-mutated triple-negative breast cancer: a clinical

Frontiers of Medicine 2024, Volume 18, Issue 2,   Pages 357-374 doi: 10.1007/s11684-023-1016-8

Abstract: p53 is mutated in half of cancer cases. However, no p53-targeting drugs have been approved.Here, we reposition decitabine for triple-negative breast cancer (TNBC), a subtype with frequent p53

Keywords: p53 mutation     triple-negative breast cancer     decitabine     DNMT1     IRF7     innate immune response    

Progress in systemic therapy for triple-negative breast cancer

Hongnan Mo, Binghe Xu

Frontiers of Medicine 2021, Volume 15, Issue 1,   Pages 1-10 doi: 10.1007/s11684-020-0741-5

Abstract: Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer with a heterogeneous

Keywords: triple-negative breast cancer     immunotherapy     targeted therapy    

Soy food consumption in relation to breast cancer modified by menopause status

YANG Rong, ZHANG Bin, YANG Shaoping, ZHANG Dan, DU Yukai

Frontiers of Medicine 2008, Volume 2, Issue 4,   Pages 348-351 doi: 10.1007/s11684-008-0066-2

Abstract: The mortality of breast cancer in Wuhan city is increasing, according to the statistics of recent yearsThis case control study was aimed to provide data for alimentary therapeutics for breast carcinomas.indicate that intake of soy foods more than 5 times per week was associated with a decreased risk of breastcancer, especially in premenopausal women.Our results indicate that alimentary therapeutics for breast cancer can be adjusted by status of menopause

Keywords: development     control     lifestyle     consumption     information    

How to judge the association of postmenopausal hormone therapy and the risk of breast cancer

Ling XU

Frontiers of Medicine 2010, Volume 4, Issue 3,   Pages 290-293 doi: 10.1007/s11684-010-0093-7

Abstract: The relevance of postmenopausal hormone therapy (HT) for breast cancer risk has been long debated, althoughThese unanswered questions include: whether HT has a positive impact on breast cancer; whether riskscancer; breast cancer in postmenopausal women using HT usually has better prognosis than that of nonusersHowever, a possible risk of breast cancer associated with long-term HT usage should not be ignored.With respect to prevention of breast cancer, regular evaluation of individual breast cancer susceptibility

Keywords: breast cancer     postmenopausal hormone therapy     unopposed estrogen therapy     combined estrogen-progestin therapy    

Transformer2 proteins protect breast cancer cells from accumulating replication stress by ensuring productive

Andrew Best,Katherine James,Gerald Hysenaj,Alison Tyson-Capper,David J. Elliott

Frontiers of Chemical Science and Engineering 2016, Volume 10, Issue 2,   Pages 186-195 doi: 10.1007/s11705-015-1540-4

Abstract: the RNA splicing regulator Transformer2 (abbreviated Tra2 ) have been reported in several types of cancerhas revealed an intimate cross-regulation between Tra2 and the highly similar Tra2 protein in human breastcancer cells, though these two proteins are encoded by separate genes created by a gene duplicationits by-pass by joint depletion of both human Tra2 proteins, revealed Tra2 proteins are essential for breastBreast cancer cells depleted for Tra2 proteins have reduced CHK1 protein levels and accumulate DNA damage

Keywords: RNA splicing     gene expression     breast cancer     DNA damage     CHK1    

The Fibrillar Matrix: Novel Avenues for Breast Cancer Detection and Treatment Review

Rasha Rezk,  Raquel Marín-García,  Annica K.B.Gad

Engineering 2021, Volume 7, Issue 10,   Pages 1375-1380 doi: 10.1016/j.eng.2021.04.024

Abstract:

Breast cancer is marked by large increases in the protein fibers around tumor cells.cancer.of normal breast tissue and non-cancerous lesions.cancer metastasis.These models will guide the development of novel mechano-based therapies against breast cancer metastasis

Keywords: Breast cancer     Tissue stiffness     Cancer metastasis     Cell migration     Bioengineered scaffold     Viscosity    

Medical applications of phytoestrogens from the Thai herb

Suchinda Malaivijitnond

Frontiers of Medicine 2012, Volume 6, Issue 1,   Pages 8-21 doi: 10.1007/s11684-012-0184-8

Abstract:

Pueraria mirifica Airy Shaw et Suvatabandhu is a medicinal plant endemic to Thailand. It has been used in Thai folklore medicine for its rejuvenating qualities in aged women and men for nearly one hundred years. Indeed, it has been claimed that P. mirifica contains active phytoestrogens (plant substances with estrogen-like activity). Using high performance liquid chromatography, at least 17 phytoestrogens, mainly isoflavones, have been isolated. Thus, fairly considerable scientific researches, both in vitro in cell lines and in vivo in various species of animals including humans, have been conducted to date to address its estrogenic activity on the reproductive organs, bones, cardiovascular diseases and other climacteric related symptoms. The antioxidative capacity and antiproliferative effect on tumor cell lines have also been assessed. In general, P. mirifica could be applicable for preventing, or as a therapeutic for, the symptoms related to estrogen deficiency in menopausal women as well as in andropausal men. However, the optimal doses for each desirable effect and the balance to avoid undesired side effects need to be calculated before use.

Keywords: white Kwao Krua     miroestrol     estrogenic activity     reproduction     osteoporosis     breast cancer     Alzheimer    

Effect of lanthanum chloride on growth of breast cancer cells and regulation of transcription

Xue LI MM , Ping HE MM , Jie XIA MM , Shiwei SONG BS , Jinhai LU BM , Yunde LIU MM ,

Frontiers of Medicine 2009, Volume 3, Issue 3,   Pages 336-340 doi: 10.1007/s11684-009-0053-2

Abstract: Lanthanum salt is a prescription drug, but its underlying functions and mechanisms are not fully understood currently. To explore the potential therapeutic value of , cytotoxicity test was applied to investigate its effects on cell proliferation. Furthermore, we observed its influence on pro-oncogene by reverse transcription polymerase chain reaction (RT-PCR). In MCF-7 cell line, repressed cell proliferation at high concentration but had no significant inhibition effect on cell growth at low concentration. However, we observed that repressed transcription at a low concentration. This may suggest that is a potent drug to inhibit the high expression of in carcinoma cells and play a clue for inhibiting the growth and invasion of tumor.

Keywords: proliferation     c-met     invasion     lanthanum chloride    

Title Author Date Type Operation

Midline2 is overexpressed and a prognostic indicator in human breast cancer and promotes breast cancer

Journal Article

Midline2 is overexpressed and a prognostic indicator in human breast cancer and promotes breast cancer

Lan Wang,Jueheng Wu,Jie Yuan,Xun Zhu,Hongmei Wu,Mengfeng Li

Journal Article

Meta-analysis of the risk factors of breast cancer concerning reproductive factors and oral contraceptive

Qiong DAI MD, Bei LIU MD, Yukai DU MM,

Journal Article

Metabolism and immunity in breast cancer

Deyu Zhang, Xiaojie Xu, Qinong Ye

Journal Article

A comprehensive information database (CID) of breast cancer patients in China

Shuai Li, Li Fu

Journal Article

Production of pectic extracts from sugar beet pulp with antiproliferative activity on a breast cancer

Jacqueline CONCHA, Caroline WEINSTEIN, María Elvira Zú?IGA

Journal Article

Breast cancer-associated fibroblasts: their roles in tumor initiation, progression and clinical applications

Aixiu Qiao,Feng Gu,Xiaojing Guo,Xinmin Zhang,Li Fu

Journal Article

Decitabine induces -mediated immune responses in p53-mutated triple-negative breast cancer: a clinical

Journal Article

Progress in systemic therapy for triple-negative breast cancer

Hongnan Mo, Binghe Xu

Journal Article

Soy food consumption in relation to breast cancer modified by menopause status

YANG Rong, ZHANG Bin, YANG Shaoping, ZHANG Dan, DU Yukai

Journal Article

How to judge the association of postmenopausal hormone therapy and the risk of breast cancer

Ling XU

Journal Article

Transformer2 proteins protect breast cancer cells from accumulating replication stress by ensuring productive

Andrew Best,Katherine James,Gerald Hysenaj,Alison Tyson-Capper,David J. Elliott

Journal Article

The Fibrillar Matrix: Novel Avenues for Breast Cancer Detection and Treatment

Rasha Rezk,  Raquel Marín-García,  Annica K.B.Gad

Journal Article

Medical applications of phytoestrogens from the Thai herb

Suchinda Malaivijitnond

Journal Article

Effect of lanthanum chloride on growth of breast cancer cells and regulation of transcription

Xue LI MM , Ping HE MM , Jie XIA MM , Shiwei SONG BS , Jinhai LU BM , Yunde LIU MM ,

Journal Article